Completed
Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia
NCT05656027
- Conditions
- Eye Diseases, Myopia, Near Vision, +3 more
- Locations
-
- Site #106 Chandler, Arizona, United States
- Site #121 Mesa, Arizona, United States
- Site #122 Phoenix, Arizona, United States
- Site #124 Phoenix, Arizona, United States